Archives
-
ATM Inhibition, Macropinocytosis, and Tumor Metabolism
2026-09-21
The reference study identifies macropinocytosis as a metabolic adaptation that allows ATM-suppressed cancer cells to survive nutrient limitation. Its combination of cell-based assays, nutrient-rescue experiments, metabolomics, and in vivo studies reveals a potential vulnerability centered on branched-chain amino acid dependence.
-
rhBNP, Selenium Recycling, and Renal Ferroptosis
2026-09-20
The reference study identifies selenocysteine lyase (SCLY)-dependent selenium recycling as a central mechanism by which recombinant human brain natriuretic peptide (rhBNP) limits ferroptosis during renal ischemia-reperfusion injury. Its integrated clinical, animal, transcriptomic, and cell-based evidence positions SCLY as a mechanistic target for acute kidney injury research while highlighting important limits to clinical translation.
-
FDA-Approved Screening for MERS-CoV Inhibitors
2026-09-19
de Wilde and colleagues used a phenotypic screen of 348 FDA-approved compounds to identify four agents that inhibited MERS-CoV replication in cell culture, including Lopinavir. The study established a practical repurposing framework and showed that the active compounds also inhibited SARS-CoV and HCoV-229E, while emphasizing that cell-culture activity requires further animal and clinical validation.
-
AZD0156: From ATM Inhibition to Assay Design
2026-09-18
AZD0156 is a selective ATM kinase inhibitor that can reveal how DNA damage response and metabolic state jointly shape cancer-cell survival. This article translates ovarian cancer findings into practical assay-design decisions, emphasizing target engagement, combination logic, phenotype selection, and experimental limitations.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-18
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only, and assay-specific dilution, fixation, retrieval, and incubation conditions must be optimized because directly matched paper evidence and complete protocol parameters were not provided.
-
Canagliflozin Hemihydrate in Metabolic Assays
2026-09-17
Canagliflozin hemihydrate provides a practical SGLT2-focused tool for separating renal glucose reabsorption inhibition from unrelated growth or mTOR effects. This workflow combines solvent-aware handling, transporter-dependent validation, and a drug-sensitized yeast counter-screen for stronger glucose metabolism research conclusions.
-
Angiotensin III and SARS-CoV-2 Receptor Binding
2026-09-17
The 2025 study by Oliveira and colleagues shows that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with particularly strong effects from N-terminally truncated peptides such as Angiotensin III and Angiotensin IV. Its antibody-based binding experiments provide a mechanistic link between renin–angiotensin signaling and viral receptor engagement, while also emphasizing that the findings require validation in cellular and physiological infection models.
-
Sodium Nitroprusside in Vascular Research
2026-09-16
Sodium Nitroprusside is a practical nitric oxide donor for separating vascular smooth muscle responsiveness from hormone-, autonomic-, and platelet-dependent effects. This guide translates sex-specific angiotensin II hypertension findings into ex vivo vessel and platelet workflows, with executable starting conditions and troubleshooting strategies.
-
TAK-242 (Resatorvid): TLR4 Inhibition Guide
2026-09-16
TAK-242, also called Resatorvid, is a selective small-molecule inhibitor used for TLR4 signaling pathway modulation and inhibition of LPS-induced inflammatory cytokine production. Product data support low-nanomolar activity in macrophage assays, while peer-reviewed mouse research links short-term TLR4 blockade with reduced posttraumatic seizure activity and glial activation.
-
TBST (Tris-Buffered Saline and Tween 20)
2026-09-15
TBST is a ready-to-use buffered detergent solution for reducing nonspecific background during antibody-based workflows, including Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It is suitable for washing, antibody dilution, and preparation of blocking solutions, but exact wash duration, detergent tolerance, and blocking composition should be validated for each assay.
-
MRSA EVs Drive IL-8–Dependent OSCC Growth
2026-09-15
A 2026 Journal of Advanced Research study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma growth. The work connects bacterial vesicle uptake with ERK/c-Jun activation, IL-8–CXCR1 signaling, CCL2 production, and JAK/STAT5A activity, with genetic and receptor-blockade experiments supporting a causal mechanism.
-
2X HyperFusion High-Fidelity Master Mix Workflow
2026-09-14
Build accurate amplicons for cloning, CRISPR validation, and immunotherapy research with a ready-to-use proofreading mix. This workflow translates high-fidelity PCR specifications into practical setup, cycling, blunt-end handling, and troubleshooting decisions.
-
U 46619 in Platelet and Vascular Research
2026-09-14
U 46619 provides a concentration-resolved way to activate TP receptors and connect platelet signaling with vascular tone. This guide turns its defined response profile into practical workflows for aggregation, serotonin release, receptor studies, and renal or hypertensive rat models.
-
Pam3CSK4: TLR1/2 Agonism for Translation
2026-09-13
A mechanism-first perspective on how Pam3CSK4 can help translational researchers connect defined TLR1/2 stimulation with macrophage biology, allergic inflammation models, and emerging neuro-immune research, while maintaining appropriate experimental boundaries.
-
Nigericin Sodium Salt for Mechanism-Aware Assays
2026-09-12
Nigericin sodium salt is a potassium ionophore for controlled ion transport across biological membranes and cytoplasmic pH regulation. This article connects its mechanistic effects with Schwartz’s framework for separating growth inhibition from cell death, helping researchers design more interpretable assays.